01541 IMMUNEONCO-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 3.83X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 4.1% | Net Margin | N/A |
| Total Debt/Equity | 28.8% | Return on Equity | N/A |
| Price/Book | 2.33X | Return on Assets | N/A |
| (HKD 4.750) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | -243.30 | -335.91 | -418.24 | -451.72 | -896.47 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +27.6 | +19.7 | +7.4 | +49.6 | N/A |
| Earnings Per Share (HKD) | -0.59 | -0.891 | -1.156 | -1.362 | -10.402 |
| Earnings Per Share Growth (%) | +33.8 | +23.0 | +15.1 | +86.9 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 2.042 | 1.773 | 2.204 | N/A | N/A |
| Auditors' Opinion | N/A | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 154.294 | 74.149 | +108.1 | 0.386 |
| Operating Result | -219.259 | -316.59 | -30.7 | -379.459 |
| Profit Before Taxation | -219.259 | -316.59 | -30.7 | -379.459 |
| Taxation | 0.029 | 0 | N/A | 0 |
| Profit /( Loss) After Taxation | -219.288 | -316.59 | -30.7 | -379.459 |
| Minority Interests | -0.708 | -0.735 | -3.7 | 0 |
| Net Profit | -218.58 | -315.855 | -30.8 | -379.459 |
| Earnings Per Share () | -0.5899 | -0.8906 | -33.8 | -1.1560 |
| Announcement Date | 2026-03-25 | 2025-03-25 | NA | 2024-03-25 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
